how to improve the results with io agents in msi gi cancer
Published 4 years ago • 279 plays • Length 18:14Download video MP4
Download video MP3
Similar videos
-
1:08
the role of neoadjuvant immunotherapy in msi-high gastric cancer
-
14:34
clin-msi: a machine learning-based approach to msi detection in endometrial cancers
-
2:09
evaluating the optimal approach for managing msi-h upper gi cancers
-
37:33
innovative approaches for the management of gastric cancer: q&a
-
4:32
immunotherapy regimens in dmmr/msi-high metastatic crc
-
4:37
toc-l series maintenance – combustion tube replacement
-
6:20
modifying your immune system to fight cancer
-
5:38
biometry basics with the iol master 700
-
4:07
how will you be monitored during your cancer treatment?
-
4:26
curing cancer in virtual reality with immunotherapy
-
0:55
the importance of testing for msi status in gastric cancers
-
1:11
remaining questions for the treatment of patients with msi/dmmr mcrc with immunotherapy
-
5:49
immunotherapy and msi status in colorectal cancer
-
44:13
prostate cancer: navigating complex treatment landscapes in oncology
-
0:35
immunotherapy for msi high colon cancer
-
9:24
msi status and immunotherapy in advanced colorectal cancer
-
1:14
current and future trends in immunotherapy for msi-h colorectal cancer
-
10:02
expert perspectives: cdk 4/6 inhibitors for er breast cancer: emerging data and future implications
-
9:22
debate 5: is there a role for adjuvant oxaliplatin in rectal cancer? - no
-
1:25
neoadjuvant immunotherapy in msi-high colorectal cancer
-
8:04
using i/o in msi-h tumors in mcrc
-
2:33
updated results for nivolumab in msi-h colorectal cancer